Osteoporosis y bifosfonatos.

Repasamos qué relación hay para tomar una decisión bien informada. Enlace para conocer el riesgo de fractura: https://www.sheffield.ac.uk/FRAX/ Hay que buscar la "herramienta de cálculo", segunda pestaña superior en el momento de elaborar este vídeo.

Capítulos:
0:00 Saludo
0:08 Qué son los bifosfonatos
0:29 A quién le interesa esto
2:40 Prescripción
3:15 Riesgos y efectos secundarios
3:53 A quiénes ayudan más los bifosfonatos
4:50 Una cosa más


Bibliografía:
U.S. Preventive Services Task Force, et al. (2018). Screening for osteoporosis to prevent fractures: U.S. Preventive Services Task Force recommendation statement. JAMA, 319(24): 2521–2531. DOI: 10.1001/jama.2018.7498. National Osteoporosis Foundation (2014).
Clinician's guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation. http://nof.org/hcp/clinicians-guide. Newberry SJ, et al. (2012). Treatment to Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis: Update of a 2007 Report.
Comparative Effectiveness Review No. 53 (AHRQ Publication No. 12-EHC023-EF). Rockville, MD: Agency for Healthcare Research and Quality. Available online: http://effectivehealthcare.ahrq.gov/i.... Qaseem A, et al. (2017).
Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians. Ann Intern Med, 166(11):818–839. DOI: 10.7326/M15-1361. Schilcher J, et al. (2014).
Risk of atypical femoral fracture during and after bisphosphonate use. New England Journal of Medicine, 371(10): 974–976. DOI: 10.1056/NEJMc1403799.
U.S. Food and Drug Administration (2010). FDA Drug Safety Communication: Safety update for osteoporosis drugs, bisphosphonates, and atypical fractures.
U.S. Food and Drug Administration. http://www.fda.gov/Drugs/DrugSafety/u.... Khan AA, et al. (2015).
Diagnosis and management of osteonecrosis of the jaw: A systematic review and international consensus. Journal of Bone and Mineral Research, 30(1): 3–23. DOI: 10.1002/jbmr.2405. .

Si te ha gustado, indícamelo, por favor. Comenta, comparte y suscríbete: no cuesta nada, pero para mí es mucho. ¡Gracias!
Contacta: [email protected]
Suscripción: https://tinyurl.com/prottech
Facebook y Twitter: @Prottech1